Well consider this also that the Repkon JV is expected to generate 15M+ per annum and the Neos deal 30M per annum (According to TTT investor day)
These are big time numbers if you consider Velo3D a US based company still has a market cap over 600M USD with 25M revs, sure Velo3D probably has a more developed product and it's revenues will likely grow quicker in the short-Medium term due to it having significant funding to achieve it's goals but it does show TTT can easily be a winner, a very big winner from this position.
I think there is plenty of mistrust though as prior TTT management promised the world and delivered nothing, but it looks like the relationship between TTT and Boeing, Repkon and Neos in particular is strong and provide the results needed to get off the ground
Not advice of course
- Forums
- ASX - By Stock
- TTT
- Ann: Review of Operations Q3 FY2022
Ann: Review of Operations Q3 FY2022, page-12
Featured News
Add TTT (ASX) to my watchlist
|
|||||
Last
9.0¢ |
Change
0.010(12.5%) |
Mkt cap ! $90.95M |
Open | High | Low | Value | Volume |
7.9¢ | 9.0¢ | 7.6¢ | $227.1K | 2.628M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 916059 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.088 |
1 | 11494 | 0.087 |
2 | 101170 | 0.085 |
1 | 8108 | 0.082 |
2 | 27970 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 916059 | 8 |
0.091 | 25000 | 2 |
0.092 | 6000 | 1 |
0.094 | 150000 | 2 |
0.095 | 532126 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
TTT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online